Thursday, February 23, 2023 2:10:27 AM
Recent TFFP News
- TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery • GlobeNewswire Inc. • 09/26/2024 11:00:00 AM
- TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:05:20 PM
- TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:42:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/14/2024 08:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:29:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/17/2024 08:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:04:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:03:36 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/07/2024 04:15:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 11:07:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:06:12 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/08/2023 09:52:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:10:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 10:28:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:26:05 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM